Tenofovir and Lamuvidine
Sep 3, 2012
Dear Dr. Benjamin,
My sister (who is in Africa) has been on second line regimen of Alluvia, Abavacir and Didanosine since February 2009. This month her doctor replaced the Abacavir and Didanosine by once a day Tenofovir and Lamivudine. She has now to take Alluvia and Tenofovir + Lamivudine. How efficacious is this combination? And what is the risk of resistance given she used to take the Lamivudine in her first-line regimen before 2009?
Response from Dr. Young
Hello and thanks for posting,
Tenofovir and lamivudine can be very effective NRTI components of treatment- as to the specifics of how well they might replace didanosine and abacavir would depend on the potential for your sister's virus to harbor drug resistance.
Fortunately, for virus that has only lamivudine resistance, the tenofovir/lamivudine combo should combine effectively with Alluvia (Kaletra).
Any time that there's a switch in treatment, one should be mindful to monitor viral load changes and the potential for new drug toxicity (in the case of tenofovir, this would certainly include kidney and bone injury).
I hope that helps, BY
Get Email Notifications When This Forum Updates or Subscribe With RSS
- Itchy Testicles After Masturbation Sign Of HIV AIDS
- Jock Itch After Receiving Oral Sex Sign Of HIV AIDS
- Muscle Ache After Unprotected Sex Without Ejaculation Sign Of HIV AIDS
- Pathophysiology Of Sexually Transmitted Diseases
- Blood Transfusions For AIDS Patients
- Does Syphilis Affect Hiv Test?
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.